Tumor volume and T2 hyperintensity changes from DeFi: A phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors Meeting Abstract
| Authors: | Alcindor, T.; Kasper, B.; Gounder, M. M.; Ratan, R.; Van Der Graaf, W. T. A.; Wilky, B. A.; Riedel, R. F.; Federman, N.; Peruzzi, A.; Moody, S.; Lim, A.; Tumminello, B.; Kummar, S.; Schöffski, P. |
| Abstract Title: | Tumor volume and T2 hyperintensity changes from DeFi: A phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.11514 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 11514 -- Meeting also presented virtually -- Source: Cinahl |
